Invert

Invert is a private, early-revenue stage software company operating at the intersection of AI/Machine Learning and bioprocess development. Its core platform automates the ingestion, harmonization, and analysis of complex, multi-source bioprocess data, serving clients in gene therapy, cell therapy, antibody development, and other biotech sectors. The company's value proposition centers on replacing manual, spreadsheet-driven workflows with an integrated AI-powered system that surfaces deviations, recommends next steps, and accelerates process development cycles. Invert appears to be in a growth phase, focusing on platform enhancement and market penetration within the biopharma and industrial biotech markets.

A purpose-built Bioprocess AI Software platform that automates the ingestion, harmonization, unification, and analysis of fragmented bioprocess data. It features modules for data acquisition, metric management, lineage tracking, pre-built and custom model training, and an AI-powered conversational interface (Invert Assist) to surface insights and recommend actions.

Invert competes in the bioprocess data analytics space against several player types: established industrial data historians (e.g., AVEVA PI System), broader SaaS-based life sciences R&D platforms (e.g., Benchling, Synthace), and the embedded software suites offered by major bioreactor manufacturers (e.g., Sartorius's SIMCA®, Thermo Fisher's Connect Platform). Its key differentiation is a singular focus on bioprocess, automated data harmonization, and a dedicated AI interface for analysis.